Selected research
Market Structure
Global Isotopes for Nuclear Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Isotopes for Nuclear Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Isotopes for Nuclear Medicine include Urenco, SHINE Medical, NTP Radioisotopes, Northwest Medical Isotopes, Medical Isotopes, ITM, CMR and Cambridge Isotope Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Isotopes for Nuclear Medicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Isotopes for Nuclear Medicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Isotopes for Nuclear Medicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Isotopes for Nuclear Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Isotopes for Nuclear Medicine Segment by Company
Urenco
SHINE Medical
NTP Radioisotopes
Northwest Medical Isotopes
Medical Isotopes
ITM
CMR
Cambridge Isotope Laboratories
Isotopes for Nuclear Medicine Segment by Type
Stable Isotope
Radioisotope
Isotopes for Nuclear Medicine Segment by Application
Hospital
Laboratory
Others
Isotopes for Nuclear Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isotopes for Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isotopes for Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isotopes for Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Isotopes for Nuclear Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isotopes for Nuclear Medicine industry.
Chapter 3: Detailed analysis of Isotopes for Nuclear Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Isotopes for Nuclear Medicinerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stable Isotope
- Radioisotope
Applications
- Hospital
- Laboratory
- Others
Companies covered
- Urenco
- SHINE Medical
- NTP Radioisotopes
- Northwest Medical Isotopes
- Medical Isotopes
- ITM
- CMR
- Cambridge Isotope Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Isotopes for Nuclear Medicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Stable Isotope
- 1.2.3 Radioisotope
- 1.3 Market Analysis by Application
- 1.3.1 Global Isotopes for Nuclear Medicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Laboratory
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Isotopes for Nuclear Medicine Growth Trends by Region
- 1.5.1 Global Isotopes for Nuclear Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Isotopes for Nuclear Medicine Market Size by Region (2021-2026)
- 1.5.3 Isotopes for Nuclear Medicine Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Isotopes for Nuclear Medicine Market Dynamics
- 2.1 Isotopes for Nuclear Medicine Industry Trends
- 2.2 Isotopes for Nuclear Medicine Industry Drivers
- 2.3 Isotopes for Nuclear Medicine Industry Opportunities and Challenges
- 2.4 Isotopes for Nuclear Medicine Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Isotopes for Nuclear Medicine Revenue by Company (2021-2026)
- 3.2 Global Isotopes for Nuclear Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Isotopes for Nuclear Medicine Key Company Head office and Area Served
- 3.4 Global Isotopes for Nuclear Medicine Company, Product Type & Application
- 3.5 Global Isotopes for Nuclear Medicine Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Isotopes for Nuclear Medicine Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Isotopes for Nuclear Medicine Players Market Share by Revenue in 2025
- 3.6.3 2025 Isotopes for Nuclear Medicine Tier 1, Tier 2, and Tier 3
4 Isotopes for Nuclear Medicine Market by Type
- 4.1 Global Isotopes for Nuclear Medicine Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Isotopes for Nuclear Medicine Market Size by Type (2021-2032)
- 4.3 Global Isotopes for Nuclear Medicine Market Size Share by Type (2021-2032)
5 Isotopes for Nuclear Medicine Market by Application
- 5.1 Global Isotopes for Nuclear Medicine Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Isotopes for Nuclear Medicine Market Size by Application (2021-2032)
- 5.3 Global Isotopes for Nuclear Medicine Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Urenco
- 6.1.1 Urenco Company Information
- 6.1.2 Urenco Business Overview
- 6.1.3 Urenco Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Urenco Isotopes for Nuclear Medicine Product Portfolio
- 6.1.5 Urenco Recent Developments
- 6.2 SHINE Medical
- 6.2.1 SHINE Medical Company Information
- 6.2.2 SHINE Medical Business Overview
- 6.2.3 SHINE Medical Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 SHINE Medical Isotopes for Nuclear Medicine Product Portfolio
- 6.2.5 SHINE Medical Recent Developments
- 6.3 NTP Radioisotopes
- 6.3.1 NTP Radioisotopes Company Information
- 6.3.2 NTP Radioisotopes Business Overview
- 6.3.3 NTP Radioisotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 NTP Radioisotopes Isotopes for Nuclear Medicine Product Portfolio
- 6.3.5 NTP Radioisotopes Recent Developments
- 6.4 Northwest Medical Isotopes
- 6.4.1 Northwest Medical Isotopes Company Information
- 6.4.2 Northwest Medical Isotopes Business Overview
- 6.4.3 Northwest Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Northwest Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
- 6.4.5 Northwest Medical Isotopes Recent Developments
- 6.5 Medical Isotopes
- 6.5.1 Medical Isotopes Company Information
- 6.5.2 Medical Isotopes Business Overview
- 6.5.3 Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
- 6.5.5 Medical Isotopes Recent Developments
- 6.6 ITM
- 6.6.1 ITM Company Information
- 6.6.2 ITM Business Overview
- 6.6.3 ITM Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 ITM Isotopes for Nuclear Medicine Product Portfolio
- 6.6.5 ITM Recent Developments
- 6.7 CMR
- 6.7.1 CMR Company Information
- 6.7.2 CMR Business Overview
- 6.7.3 CMR Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 CMR Isotopes for Nuclear Medicine Product Portfolio
- 6.7.5 CMR Recent Developments
- 6.8 Cambridge Isotope Laboratories
- 6.8.1 Cambridge Isotope Laboratories Company Information
- 6.8.2 Cambridge Isotope Laboratories Business Overview
- 6.8.3 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Product Portfolio
- 6.8.5 Cambridge Isotope Laboratories Recent Developments
7 North America
- 7.1 North America Isotopes for Nuclear Medicine Market Size (2021-2032)
- 7.2 North America Isotopes for Nuclear Medicine Market Size by Type
- 7.2.1 North America Isotopes for Nuclear Medicine Market Size by Type (2021-2026)
- 7.2.2 North America Isotopes for Nuclear Medicine Market Size by Type (2027-2032)
- 7.2.3 North America Isotopes for Nuclear Medicine Market Share by Type (2021-2032)
- 7.3 North America Isotopes for Nuclear Medicine Market Size by Application
- 7.3.1 North America Isotopes for Nuclear Medicine Market Size by Application (2021-2026)
- 7.3.2 North America Isotopes for Nuclear Medicine Market Size by Application (2027-2032)
- 7.3.3 North America Isotopes for Nuclear Medicine Market Share by Application (2021-2032)
- 7.4 North America Isotopes for Nuclear Medicine Market Size by Country
- 7.4.1 North America Isotopes for Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 7.4.3 North America Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 7.4.4 North America Isotopes for Nuclear Medicine Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Isotopes for Nuclear Medicine Market Size (2021-2032)
- 8.2 Europe Isotopes for Nuclear Medicine Market Size by Type
- 8.2.1 Europe Isotopes for Nuclear Medicine Market Size by Type (2021-2026)
- 8.2.2 Europe Isotopes for Nuclear Medicine Market Size by Type (2027-2032)
- 8.2.3 Europe Isotopes for Nuclear Medicine Market Share by Type (2021-2032)
- 8.3 Europe Isotopes for Nuclear Medicine Market Size by Application
- 8.3.1 Europe Isotopes for Nuclear Medicine Market Size by Application (2021-2026)
- 8.3.2 Europe Isotopes for Nuclear Medicine Market Size by Application (2027-2032)
- 8.3.3 Europe Isotopes for Nuclear Medicine Market Share by Application (2021-2032)
- 8.4 Europe Isotopes for Nuclear Medicine Market Size by Country
- 8.4.1 Europe Isotopes for Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 8.4.3 Europe Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 8.4.4 Europe Isotopes for Nuclear Medicine Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Isotopes for Nuclear Medicine Market Size (2021-2032)
- 9.2 China Isotopes for Nuclear Medicine Market Size by Type
- 9.2.1 China Isotopes for Nuclear Medicine Market Size by Type (2021-2026)
- 9.2.2 China Isotopes for Nuclear Medicine Market Size by Type (2027-2032)
- 9.2.3 China Isotopes for Nuclear Medicine Market Share by Type (2021-2032)
- 9.3 China Isotopes for Nuclear Medicine Market Size by Application
- 9.3.1 China Isotopes for Nuclear Medicine Market Size by Application (2021-2026)
- 9.3.2 China Isotopes for Nuclear Medicine Market Size by Application (2027-2032)
- 9.3.3 China Isotopes for Nuclear Medicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Isotopes for Nuclear Medicine Market Size (2021-2032)
- 10.2 Asia Isotopes for Nuclear Medicine Market Size by Type
- 10.2.1 Asia Isotopes for Nuclear Medicine Market Size by Type (2021-2026)
- 10.2.2 Asia Isotopes for Nuclear Medicine Market Size by Type (2027-2032)
- 10.2.3 Asia Isotopes for Nuclear Medicine Market Share by Type (2021-2032)
- 10.3 Asia Isotopes for Nuclear Medicine Market Size by Application
- 10.3.1 Asia Isotopes for Nuclear Medicine Market Size by Application (2021-2026)
- 10.3.2 Asia Isotopes for Nuclear Medicine Market Size by Application (2027-2032)
- 10.3.3 Asia Isotopes for Nuclear Medicine Market Share by Application (2021-2032)
- 10.4 Asia Isotopes for Nuclear Medicine Market Size by Country
- 10.4.1 Asia Isotopes for Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 10.4.3 Asia Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 10.4.4 Asia Isotopes for Nuclear Medicine Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Type
- 11.2.1 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Application
- 11.3.1 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country
- 11.4.1 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Isotopes for Nuclear Medicine Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst